about
Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer.Clinical Application of Poly(ADP-Ribose) Polymerase Inhibitors in High-Grade Serous Ovarian Cancer.A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer.Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast CancerClinical tumor staging of adenocarcinoma of the esophagus and esophagogastric junctionDNA Repair Deficiency in Breast Cancer: Opportunities for Immunotherapy
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Eileen Parkes
@en
Eileen Parkes
@nl
type
label
Eileen Parkes
@en
Eileen Parkes
@nl
prefLabel
Eileen Parkes
@en
Eileen Parkes
@nl
P31
P496
0000-0002-7855-3698